Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 8, 2018
Context: The registrant is an emerging growth company. This filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. The company intends to utilize the material contained in Exhibit 99.1 (Investor Presentation dated January 2018) for these communications.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding investor communications and does not contain a financial statement or performance summary.
Material Changes
No material changes to financial performance or operations are reported in this specific filing text. The document solely references the availability of an investor presentation for upcoming events.
Guidance, Outlook, and Risks
Management Commentary: Executive officers have scheduled upcoming presentations for investors and analysts.
Legal Status of Information: The information provided in this Item 7.01 and the referenced Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated January 2018) for actual financial data and strategic outlook, as this 8-K only references it.
- Confirm the company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.
- Note that the information in this filing is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.